🔎 Trials Near Me

Home › Chronic Myeloid Leukemia › Wisconsin › Milwaukee

Chronic Myeloid Leukemia clinical trials in Milwaukee, WI

5 studies for Chronic Myeloid Leukemia are looking for participants at sites in and around Milwaukee (within about 30 miles). Open a study to see who can join and how to contact the study team.

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • and 6 more
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

RecruitingPhase 2
  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT04838041

Asciminib Roll-over Study

RecruitingPhase 4
  • Medical College of Wisconsin, Milwaukee
Ages 7 to 100 · All sexes · Updated Jul 6, 2026 · NCT04877522

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • Children's Hospital of Wisconsin, Milwaukee
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RecruitingObservational study
  • Children's Hospital of Wisconsin, Milwaukee
Ages 0 to 38 · All sexes · Updated Jun 4, 2026 · NCT06131801

About Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is a cancer of the white blood cells. It usually affects older adults. Learn about symptoms, genetics, and treatment.

More about Chronic Myeloid Leukemia on MedlinePlus

Chronic Myeloid Leukemia trials in other cities

Other studies in Milwaukee

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.